Two Instruments, Two Questions: How Much and Which One

Every research peptide raises two separate analytical questions. Is this actually the molecule it is supposed to be? And what fraction of the vial is that molecule rather than something else? Mass spectrometry settles the first question and reversed-phase HPLC settles the second. Neither one covers both, which is why any analysis worth reading reports both.

Mass spectrometry answers “what is it”

Chromatography can show that a sample is homogeneous without saying what the homogeneous substance actually is. Mass spectrometry closes that gap: the sample is ionized, mass-to-charge ratio is measured, and the observed molecular weight can be set against the theoretical weight calculated from the sequence.

Peptide work relies on two ionization methods. ESI-MS, electrospray, generates multiply charged ions and couples naturally to liquid chromatography, so an LC-MS run can separate and identify in one pass. MALDI-TOF embeds the sample in a matrix, ionizes it with a laser pulse and measures flight time to the detector; it leans toward singly charged ions and copes better with salts.

Theoretical and observed mass belong side by side in the report. Agreement inside the instrument’s stated accuracy confirms identity. A gap equal to one residue’s mass points to a deletion sequence, a gap of +16 suggests oxidation, and +1 can indicate deamidation.

RP-HPLC answers “how much of it”

In reversed-phase HPLC the dissolved sample is driven through a column packed with a hydrophobic stationary phase, usually C18-bonded silica. A gradient of increasing organic solvent, typically acetonitrile against water with a little trifluoroacetic acid in both, elutes compounds progressively in order of hydrophobicity, and a UV detector at the outlet plots absorbance against time to produce the chromatogram.

The target peptide shows up as the main peak, while synthesis-related impurities arrive as their own peaks: deletion sequences short a residue, truncated chains, incompletely deprotected intermediates, and oxidation or deamidation products. Purity is quoted as main peak area over total peak area.

Three variables that move the percentage

• Detection wavelength. Peptide bonds absorb near 214 nm while aromatic side chains absorb near 280 nm, so a figure taken at 214 nm and one taken at 280 nm are not comparable – the latter under-reports anything without aromatic residues. The wavelength has to be stated.
• Gradient shallowness. Steep gradients compress everything into a narrow window and can bury a close-eluting impurity inside the main peak, where a shallow gradient would have pulled the two apart. Gradient choice alone can make two laboratories report meaningfully different purity for identical material.
• Peak shape. A symmetrical peak is consistent with a single compound. Shouldering, tailing or a flattened apex frequently signals co-elution, with two species leaving the column at nearly the same moment and getting counted as one.

All of which is why the chromatogram carries more information than the percentage does. Looking at the trace tells you whether the non-target 2% is one substantial impurity or a scattering of trace peaks, and whether the main peak is genuinely clean.

The number neither method produces

Neither technique reveals how much peptide is actually in the vial. Lyophilized peptides come as salts, commonly trifluoroacetate, and they are hygroscopic, so a vial labeled 10 mg holds peptide plus counter-ion plus residual water. HPLC purity is a ratio among peptide species and is silent on that mass balance entirely.

Net peptide content comes from amino acid analysis or elemental nitrogen analysis, and usually lands somewhere between 70% and 90%. Water content comes from Karl Fischer titration. Lacking those figures, any concentration calculated gravimetrically from vial weight carries an error nobody has quantified, and comparisons between suppliers quoting HPLC purity alone are not like-for-like.

Three numbers, read together

A complete picture needs identity confirmed by mass spectrometry, purity by HPLC at a stated wavelength with the chromatogram available, and net peptide content. Drop any one and the remainder degrades in a predictable way. High purity without confirmed identity gives you a pure unknown. Confirmed identity without a stated purity gives you the right molecule keeping unknown company. Both of those without net content still leaves the concentration unknown.

Related reading: how to read a peptide certificate of analysis and peptide storage and stability.

All products referenced are supplied for laboratory research use only and are not approved for human consumption or for clinical or veterinary use.

Related listings. PT-141 and Melanotan-II put this to the sharpest test in the catalog — a single dalton apart, and only distinguishable where the calculated mass is stated.